These findings underscore the complexity of Nrf2 regulation in COPD, involving metabolic enzymes, xenobiotic metabolizers, danger signals, and transcriptional regulators, offering diverse potential therapeutic targets. The gene discussed is NFE2L2; the disease is chronic obstructive pulmonary disease.